Abstract
Alternative avenues of ovarian cancer treatment are needed: by combining type 2 diabetes drugs with an oncolytic virus, an antitumor agent capable of targeting, infecting, and killing tumor cells, while inducing an antitumor immune response; the proposed approach would fulfill this need and potentially offer ovarian cancer patients a new avenue for treatment.
Status
Undergraduate
Department
Biological Sciences
College
College of Arts and Sciences
Campus
Athens
Faculty Mentor
Fabian Benencia
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-No Derivative Works 4.0 International License.
Effects of Type 2 Diabetes Medications on Human and Mouse Ovarian Cancer Cells
Alternative avenues of ovarian cancer treatment are needed: by combining type 2 diabetes drugs with an oncolytic virus, an antitumor agent capable of targeting, infecting, and killing tumor cells, while inducing an antitumor immune response; the proposed approach would fulfill this need and potentially offer ovarian cancer patients a new avenue for treatment.